Enhanced production of antibodies utilizing insolubilized immune
complexes
    2.
    发明授权
    Enhanced production of antibodies utilizing insolubilized immune complexes 失效
    利用不溶性免疫复合物增强产生抗体

    公开(公告)号:US4879225A

    公开(公告)日:1989-11-07

    申请号:US24632

    申请日:1987-03-11

    摘要: A method for enhancing production of antibodies through immunization with insolubilized immune complexes is disclosed. Purified antigen or heterogeneous antigen mixtures may be combined with polyclonal or monoclonal antibody and the resultant complex bound to insolubilized protein A to form insolubilized immune complexes. Methods for improving the immunogenicity of a soluble antigen and for producing monoclonal anti-idiotypic antibodies are also disclosed. Monoclonal antibodies that are specific for a distinct, as yet unrecognized epitope may be produced by another disclosed method. Insolubilized immune complexes, comprising antigen and antibody that is either directly linked to Sepharose.RTM. or absorbed onto insolubolized protein A, and immunosorbents, comprising antibody absorbed onto insolubilized protein A, are also disclosed.

    摘要翻译: 公开了通过用不溶性免疫复合物进行免疫来增强抗体产生的方法。 纯化的抗原或异源抗原混合物可以与多克隆或单克隆抗体组合,并且所得复合物与不溶蛋白A结合以形成不溶性免疫复合物。 还公开了用于改善可溶性抗原的免疫原性和用于产生单克隆抗独特型抗体的方法。 对于不同的尚未识别的表位特异的单克隆抗体可以通过另一公开的方法产生。 还公开了包含与Sepharose TM直接连接或被吸收到非溶解蛋白A上的抗原和抗体的免溶质免疫复合物,以及包含吸收在不溶蛋白A上的抗体的免疫吸附剂。

    Enhanced production of antibodies utilizing insolubilized immune
complexes
    3.
    发明授权
    Enhanced production of antibodies utilizing insolubilized immune complexes 失效
    利用不溶性免疫复合物增强产生抗体

    公开(公告)号:US5084396A

    公开(公告)日:1992-01-28

    申请号:US579627

    申请日:1990-09-07

    摘要: A method for enhancing production of antibodies through immunization with insolubilized immune complexes is disclosed. Purified antigen or heterogeneous antigen mixtures may be combined with polyclonal or monoclonal antibody and the resultant complex bound to an insolubilized matrix to form insolubilized immune complexes. Methods for improving the immunogenicity of a soluble antigen and for producing monoclonal anti-iodiotypic antibodies are also disclosed. Monoclonal antibodies that are specific for a distinct, as yet unrecognized epitope may be produced by another disclosed method . Insolubilized immune complexes, comprising antigen and antibody that is ether directly linked to Sepharose.RTM. or absorbed onto insolubilized protein A, and immunosorbents, comprising antibody absorbed onto insolubilized protein A, are also disclosed.

    摘要翻译: 公开了通过用不溶性免疫复合物进行免疫来增强抗体产生的方法。 纯化的抗原或异源抗原混合物可以与多克隆或单克隆抗体组合,并且所得复合物与不溶性基质结合以形成不溶性免疫复合物。 还公开了用于改善可溶性抗原的免疫原性和用于产生单克隆抗碘代抗体的方法。 对于不同的尚未识别的表位特异的单克隆抗体可以通过另一公开的方法产生。 还公开了包含与Sepharose TM直接连接或被吸收到不溶蛋白A上的醚的抗原和抗体的免溶质免疫复合物,以及包含吸收在不溶蛋白A上的抗体的免疫吸附剂。